Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. KRG
2. SPY
3. SKA-B
4. ALAR
5. EXC
6. PBA
7. CCH:LN
8. META
9. BAJAJHFL:I

Go back to Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

Viridian Therapeutics, Inc. (VRDN) Misses Q2 EPS by 16c

August 15, 2022 7:09 AM EDT

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q2 EPS of ($1.06), $0.16 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $256 thousand versus the consensus estimate of $270.33 thousand.

Cash, cash equivalents and short-term investments were $161.2 million as of June 30, 2022, compared with $197 million as... More